SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zydus Lifesciences informs about ESG rating

10 Apr 2026 Evaluate
Zydus Lifesciences has informed that ESG Risk Assessments and Insights (‘ESGRAIL’), a SEBI registered ESG Rating Provider has assigned overall ESG rating of 68 (last year 66) to the Company. The report was received by way of an email on April 9, 2026, at 15:30 hours. The Company had not engaged ESGRAIL for the ESG Rating. ESGRAIL has independently prepared the report based on publicly available information. This disclosure is made in compliance with the provisions of regulation 30 of the Listing Regulations read with the SEBI Circular.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

915.45 13.30 (1.47%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×